CSF samples from patients with Alzheimer’s disease demonstrated reduced LRP1 and LRP2-bound Aβ, which may contribute to the elevated brain Aβ in Alzheimer’s disease [118]. This evidence concerns the gene LRP1 and early-onset autosomal dominant Alzheimer disease.